Endothelial cells as targets of immune checkpoint blockade
The tumor vasculature acts as the gatekeeper to the tumor microenvironment, thus regulating the ability of immune cells to roll, anchor, and cross the endothelium from blood to tissue. While the role of endothelial cells (EC) in T Cell migration and extravasation has been extensively studied, the ability of ECs to control T Cell function is less well appreciated. Several well-characterized regulators of T Cell function are expressed by ECs, while others are induced by soluble factors required for EC development and differentiation. Targeting the molecules expressed by immunomodulatory ECs may provide approaches to improve tumor immunotherapy.
Authors
- F Stephen Hodi
- Matthew H. Taylor (ORCID: https://orcid.org/0000-0003-2409-9001)
- Alan J. Korman (ORCID: https://orcid.org/0000-0002-1142-8542)
Institutions
- Providence Portland Medical Center (US)
- Dana-Farber Cancer Institute (US)
- Bluebird Bio (United States) (US)
Publication Details
- Journal
- Journal for ImmunoTherapy of Cancer
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1136/jitc-2025-013144
- Primary Topic
- Angiogenesis and VEGF in Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00